找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Ophthalmic Oncology; Uveal Tumors Bertil E. Damato,Arun D. Singh Book 2019Latest edition Springer Nature Switzerland AG 2019 Cance

[復(fù)制鏈接]
查看: 28441|回復(fù): 67
樓主
發(fā)表于 2025-3-21 16:14:26 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Clinical Ophthalmic Oncology
副標(biāo)題Uveal Tumors
編輯Bertil E. Damato,Arun D. Singh
視頻videohttp://file.papertrans.cn/229/228131/228131.mp4
概述Written by internationally renowned experts.Divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma.New edition inc
圖書封面Titlebook: Clinical Ophthalmic Oncology; Uveal Tumors Bertil E. Damato,Arun D. Singh Book 2019Latest edition Springer Nature Switzerland AG 2019 Cance
描述.Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors‘ private collections, histopathologic microphotographs, imaging studies, and crisp illustrations...Clinical Ophthalmic Oncology‘s .clinically focused and user-friendly format allows for rapid retrieval of informationin daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehe
出版日期Book 2019Latest edition
關(guān)鍵詞Cancer staging; Complications; Immunology; Targeted therapy; Tumor associated diseases; clinical ophthalm
版次3
doihttps://doi.org/10.1007/978-3-030-17879-6
isbn_softcover978-3-030-17881-9
isbn_ebook978-3-030-17879-6
copyrightSpringer Nature Switzerland AG 2019
The information of publication is updating

書目名稱Clinical Ophthalmic Oncology影響因子(影響力)




書目名稱Clinical Ophthalmic Oncology影響因子(影響力)學(xué)科排名




書目名稱Clinical Ophthalmic Oncology網(wǎng)絡(luò)公開度




書目名稱Clinical Ophthalmic Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Ophthalmic Oncology被引頻次




書目名稱Clinical Ophthalmic Oncology被引頻次學(xué)科排名




書目名稱Clinical Ophthalmic Oncology年度引用




書目名稱Clinical Ophthalmic Oncology年度引用學(xué)科排名




書目名稱Clinical Ophthalmic Oncology讀者反饋




書目名稱Clinical Ophthalmic Oncology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:23:49 | 只看該作者
Uveal Melanoma: Resection Techniques,. These operations can be undertaken as primary procedures, with or without neoadjuvant radiotherapy, or they can be performed as treatment for exudative and neovascular complications (i.e., ‘toxic tumor syndrome’).
板凳
發(fā)表于 2025-3-22 03:05:26 | 只看該作者
地板
發(fā)表于 2025-3-22 08:23:12 | 只看該作者
978-3-030-17881-9Springer Nature Switzerland AG 2019
5#
發(fā)表于 2025-3-22 10:08:39 | 只看該作者
6#
發(fā)表于 2025-3-22 13:29:51 | 只看該作者
http://image.papertrans.cn/c/image/228131.jpg
7#
發(fā)表于 2025-3-22 17:18:51 | 只看該作者
8#
發(fā)表于 2025-3-23 01:05:27 | 只看該作者
Anna-Marie Metz,Heinz-Jürgen Rothe. These operations can be undertaken as primary procedures, with or without neoadjuvant radiotherapy, or they can be performed as treatment for exudative and neovascular complications (i.e., ‘toxic tumor syndrome’).
9#
發(fā)表于 2025-3-23 02:14:50 | 只看該作者
10#
發(fā)表于 2025-3-23 06:52:30 | 只看該作者
Andrew Marshall,Sreedhar Natarajan the process of defining different tumor classes and correlating these with each other in a logical manner based on the putative cell of origin. Classification also involves “grading” of tumor cell morphological features and consideration of their immunohistochemical and genetic profiles. It does no
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 21:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
临沧市| 灵武市| 徐州市| 通辽市| 望奎县| 肇东市| 临朐县| 商水县| 山丹县| 同仁县| 洮南市| 乐业县| 和静县| 肥乡县| 曲松县| 蓬安县| 禹城市| 平远县| 开封县| 安图县| 鄯善县| 富顺县| 木兰县| 溆浦县| 平度市| 南和县| 花垣县| 云南省| 临泽县| 龙游县| 江川县| 常德市| 玛沁县| 祁门县| 巍山| 新竹市| 桑日县| 社旗县| 鲜城| 马山县| 清原|